Societal CDMO, Inc. Share Price Börse Stuttgart
Equities
RAH
US75629F1093
Pharmaceuticals
Sales 2022 | 90.21M 84.22M 7.52B | Sales 2023 | 94.64M 88.35M 7.89B | Capitalization | 36.73M 34.29M 3.06B |
---|---|---|---|---|---|
Net income 2022 | -19M -17.74M -1.58B | Net income 2023 | -13M -12.14M -1.08B | EV / Sales 2022 | 1.72 x |
Net Debt 2022 | 29.21M 27.27M 2.43B | Net Debt 2023 | 34.26M 31.98M 2.85B | EV / Sales 2023 | 0.75 x |
P/E ratio 2022 |
-4.34
x | P/E ratio 2023 |
-2.5
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.05% |
Latest transcript on Societal CDMO, Inc.
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |